UPDATE: Herbalife (HLF) Reportedly Not Aware of FTC Probe

Go back to UPDATE: Herbalife (HLF) Reportedly Not Aware of FTC Probe

Herbalife (HLF) Responds to Headlines, Unaware of Any Federal Probe

February 4, 2013 1:11 PM EST

Herbalife (NYSE: HLF) today issued the following statement following misleading and inaccurate information in the marketplace this morning:

Other than the voluntary dialogue with regulators, which we communicated on our January investor day, we are unaware of any other regulatory interest and/or... More

UPDATE: Herbalife (HLF) Moves Higher as Citron Comments

February 4, 2013 10:14 AM EST

(Updated - February 4, 2013 10:17 AM EST)

Herbalife (NYSE: HLF) shares are moving higher off of lows amid comments from research firm Citron Research Monday morning.

The firm issued the following post on... More

StreetInsider.com Pre-Open Movers 02/04: (APKT) (RMTI) (SONS) Higher; (HLF) (BUD) (NUS) Lower (more...)

February 4, 2013 9:38 AM EST

Acme Packet (NASDAQ: APKT) 23% HIGHER; Oracle entered into an agreement to acquire Acme Packet for $29.25 per share or approximately $1.7 billion, net of Acme Packet's cash.

Rockwell Medical (NASDAQ: RMTI) 22% HIGHER; announced successful topline results from the PRIME clinical study of Soluble Ferric Pyrophosphate (SFP), its investigational iron-delivery drug currently in Phase 3 clinical studies for the treatment of iron deficiency in hemodialysis patients. The PRIME study demonstrated that regular administration of SFP-iron via dialysate reduced... More

MLM Stocks on Watch on Reports of Herbalife (HLF) Probe

February 4, 2013 8:18 AM EST

With shares of Herbalife (NYSE: HLF) down 11 percent early Monday on reports of an FTC probe, MLM peers are also on watch.

The New York Post, after the FTC responded to a Freedom of Information Law request by The Post, the existence... More

Herbalife (HLF) Slammed; FTC Opens Probe as Multitude of Complaints Released

February 4, 2013 6:46 AM EST

Herbalife (NYSE: HLF) has been a controversial stock over the last few weeks as Pershing Square's Bill Ackman as more than publicly proclaimed his disdain for the stock. Ackman might get another reason to smile Monday as regulatory officials are taking a harder look at the... More